These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19301459)

  • 21. Seeking a cure for AIDS.
    Laurence J
    AIDS Read; 2008 May; 18(5):228, 234. PubMed ID: 18589476
    [No Abstract]   [Full Text] [Related]  

  • 22. Universal voluntary HIV testing and immediate antiretroviral therapy.
    Wilson DP
    Lancet; 2009 Mar; 373(9669):1077-8; author reply 1080-1. PubMed ID: 19328991
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral lipomatosis in antiretroviral therapy-associated lipodystrophy syndrome.
    Shetty K
    J Oral Maxillofac Surg; 2007 Oct; 65(10):2095-9. PubMed ID: 17884546
    [No Abstract]   [Full Text] [Related]  

  • 24. Encouraging data on quality of life reported for IL-2 therapy.
    AIDS Patient Care STDS; 1996 Oct; 10(5):314-5. PubMed ID: 11361537
    [No Abstract]   [Full Text] [Related]  

  • 25. Interleukin-2 (IL-2, Proleukin) and immune function.
    Proj Inf Perspect; 2003 Jan; (35):16. PubMed ID: 12647677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV rules.
    Lynn T
    Br Dent J; 2009 May; 206(10):508-9. PubMed ID: 19461600
    [No Abstract]   [Full Text] [Related]  

  • 27. Report from the 16th Conference on Retroviruses and Opportunistic Infections. No clinical benefit from adding IL-2 to ART.
    Henry K
    J Watch AIDS Clin Care; 2009 Apr; 21(4):29-30. PubMed ID: 19544613
    [No Abstract]   [Full Text] [Related]  

  • 28. NIH launches interleukin-2 study.
    AIDS Patient Care STDS; 1998 Jan; 12(1):68. PubMed ID: 11361897
    [No Abstract]   [Full Text] [Related]  

  • 29. [Earlier case finding and immediate treatment of HIV: Time2Act].
    van Bergen JE
    Ned Tijdschr Geneeskd; 2015; 159():A9487. PubMed ID: 26271176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orphanhood predicts delayed access to care in Ugandan children.
    Ntanda H; Olupot-Olupot P; Mugyenyi P; Kityo C; Lowes R; Cooper C; Lima V; Mills E
    Pediatr Infect Dis J; 2009 Feb; 28(2):153-5. PubMed ID: 19131904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the need for ART being grossly underestimated?
    England R
    Lancet; 2006 Jul; 368(9532):281. PubMed ID: 16860686
    [No Abstract]   [Full Text] [Related]  

  • 32. Benefit of IL-2 therapy in HIV patients confirmed.
    Abrams D
    Am Fam Physician; 2001 Jun; 63(12):2424. PubMed ID: 11430457
    [No Abstract]   [Full Text] [Related]  

  • 33. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.
    Thai S; Koole O; Un P; Ros S; De Munter P; Van Damme W; Jacques G; Colebunders R; Lynen L
    Trop Med Int Health; 2009 Sep; 14(9):1048-58. PubMed ID: 19573140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological responses during a virologically failing antiretroviral regimen are associated with in vivo synonymous mutation rates of HIV type-1 env.
    Mens H; Jørgensen LB; Kronborg G; Schønning K; Benfield T
    Antivir Ther; 2009; 14(3):413-22. PubMed ID: 19474475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The marriage of science and optimized HIV care in resource-limited settings.
    Calmy A; Pizzocolo C; Pizarro L; Brücker G; Murphy R; Katlama C;
    AIDS; 2008 Nov; 22(17):2227-30. PubMed ID: 18981761
    [No Abstract]   [Full Text] [Related]  

  • 36. A study of rectal mucosa administration of IL-2 in treatment of HIV/AIDS: a novel method for the treatment of HIV/AIDS.
    Zhang K; Xing H; Ren Y; Lu ZZ; Hou YD
    AIDS; 2008 Oct; 22(16):2222-4. PubMed ID: 18832891
    [No Abstract]   [Full Text] [Related]  

  • 37. [Can antiretroviral treatment eradicate Prurigo nodularis in HIV infected patients?].
    Ouattara I; Eholié SP; Aoussi E; Bissagnéne E; Raffi F
    Med Mal Infect; 2009 Jun; 39(6):415-6. PubMed ID: 19423251
    [No Abstract]   [Full Text] [Related]  

  • 38. T cell turnoff.
    Nogrady B
    Sci Am; 2007 Dec; 297(6):10-1. PubMed ID: 18237091
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.
    Aberg JA; Kaplan JE; Libman H; Emmanuel P; Anderson JR; Stone VE; Oleske JM; Currier JS; Gallant JE;
    Clin Infect Dis; 2009 Sep; 49(5):651-81. PubMed ID: 19640227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.